Tycoon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 29-12-2024
- Paid Up Capital ₹ 0.10 M
as on 29-12-2024
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.30 M
as on 29-12-2024
- Revenue %
(FY 2019)
- Profit -6835.29%
(FY 2019)
- Ebitda -197.54%
(FY 2019)
- Net Worth -1.68%
(FY 2019)
- Total Assets -27.10%
(FY 2019)
About Tycoon Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.30 M.
Ramesh Khurana and Suman Khurana serve as directors at the Company.
- CIN/LLPIN
U24239DL2002PTC115809
- Company No.
115809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Tycoon Pharmaceuticals Private Limited offer?
Tycoon Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Piles, Fissures & Fistula.
Who are the key members and board of directors at Tycoon Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Khurana  | Director | 13-Jun-2002 | Current |
| Suman Khurana | Director | 01-Oct-2013 | Current |
Financial Performance of Tycoon Pharmaceuticals.
Tycoon Pharmaceuticals Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 6835.29% decrease in profit. The company's net worth dipped by a decrease of 1.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tycoon Pharmaceuticals?
In 2019, Tycoon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Branch Manager Creation Date: 25 Oct 2002 | ₹0.30 M | Open |
How Many Employees Work at Tycoon Pharmaceuticals?
Unlock and access historical data on people associated with Tycoon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tycoon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tycoon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
